Business Wire

Alps Electric to Exhibit at World Internet of Things Expo

Jaa

Japan’s leading electronic component manufacturer, Alps Electric Co., Ltd., (Alps Electric) (TOKYO:6770)(President: Toshihiro Kuriyama; headquartered in Tokyo) will be exhibiting at the World Internet of Things Expo (WIOT) at the Wuxi Taihu International Expo Centre, Wuxi, Jiangsu, China, from Sunday, September 10, 2017.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170904005063/en/

Alps Electric Sensor Network Module (Photo: Business Wire)

Alps Electric Sensor Network Module (Photo: Business Wire)

Alps Electric will be demonstrating its IoT sensor module, a combination of sensor and telecommunication technologies, both of which are specialties of the company, at the World Internet of Things Expo (WIOT). Composed of small, low-power-consuming, highly accurate sensors and a telecommunication module, it enables measurement of such environmental data as atmospheric pressure, temperature and humidity, and illuminance, as well as 6-axis (acceleration and geomagnetic) sensing.

Verification tests using the IoT sensor module are already conducted by many partner companies in Japan. A variety of IoT solutions based on the test results, including remote control of agriculture and preventive maintenance of factories, are being introduced at the exhibition site.

If you come to WIOT, visit the Alps Electric booth.

Outline of the exhibition

Period: September 10–13, 2017

Place: Wuxi Taihu International Expo Centre (Wuxi, Jiangsu)

Zone: A1_05, Building A1
 

Products to be exhibited

[IoT smart module]
- Sensor Network Module
[V2X module]

...and more

 

Sensor Network Module

  • Bluetooth® is introduced along with long-life operation with a button cell.
    The cell life is about one year, provided that all sensors are activated every minute.
  • A micro computer is built in. Sophisticated sensor control contributes to low power consumption.
  • A wide variety of sensors are mounted: atmospheric pressure, temperature/humidity, UV/illuminance, and 6-axis (acceleration and geomagnetic) sensors
  • Small-sized module to be built into a variety of devices
    High-density package realizes a dimension of 18.5 x 5.6 x 3.4 (mm). Perfect for wearable devices.

Core Technologies of Alps Electric

Three core technology areas of Alps Electric are human-machine interfaces, sensors, and connectivity. By deepening and merging the technologies, the company continues to develop electronic components that have real value to customers. In the human-machine interface and sensor areas, it has business with 2,000 customers worldwide in the smartphone and car industries in the main, and in the connectivity area, Alps was one of the first companies in the industry that commenced mass production of V2X (V2V and V2I) module, thus constantly delivering results.

Efforts of Alps Electric in the Chinese Market

In 1984, Alps Electric started exporting plants to produce color TV components for the start of its business in China. Based on the philosophy “Rooted in a local community and contribute to the local industry,” the company has six manufacturing bases, three development bases, and seven sales offices in Wuxi, Beijing, Shanghai, Dalian, and Tianjin. The company also established a joint venture named Shenyang Xikang Alps Technologies Company Limited with Xikang (China) as a product development company in 2012 and is developing products for the healthcare market.

About Alps Electric

Company name: Alps Electric Co., Ltd.
Date of establishment: November 1, 1948
Registered capital:38 billion 730 million yen (as of March 31, 2017)
Number of employees: 42,053 people (Alps Group as of March 31, 2017)
Number of employees: 5,588 people (Alps Electric Co., Ltd. as of March 31, 2017)
Net revenue: 753 billion 262 million yen (Alps Group as of March 2017)
Net revenue: 374 billion 382 million yen (Alps Electric Co., Ltd. as of March 2017)

Contact information

Inquiry about this press release to:
Alps Electric Co., Ltd.
Asagi Tsukahara, +81-70-3611-3533
Public Relations Team
Corporate Planning Office
asagi.tsukahara@jp.alps.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 14:00Tiedote

Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines

Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 11:10Tiedote

Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest

Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 18:13Tiedote

Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,

Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 17:00Tiedote

Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With

Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 16:41Tiedote

Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel

Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 15:00Tiedote

Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme